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Abstract 
NKX2-3 gene is a member of the homeobox, NKX 
family.  
The gene encodes a homeodomain-containing 
transcription factor. GO (gene ontology) annotations 
related to this gene include sequence-specific DNA 
binding and gene-specific transcription factor 
activity. NKX2-3 is essential for normal 
development and functions of the small intestine and 
spleen of embryonic and adult mice. Disruption of 
Nkx2-3 in mice results in postnatal lethality and 
abnormal development of the small intestine and the 
spleen.  
Villus formation in the small intestine appears 
considerably delayed in Nkx2-3(null) fetuses due to 
reduced proliferation of the epithelium, while 
massively increased growth of crypt cells follows in 
surviving adults.  
A complex intestinal malabsorption phenotype and 
striking abnormalities of gut-associated lymphoid 
tissue and spleen suggest deranged leukocyte 
homing. RT-PCR and immunohistochemistry 
revealed that NKX2-3 controls regional expression 
of leukocyte homing coreceptor mucosal addressin 
cell adhesion molecule-1 (MAdCAM-1) in 
specialized endothelial cells of the viscera. This 
indicates a potential role for NXK2-3 in establishing 
the developmental and positional cues  
in endothelia that regulate leukocyte homing through 
local control of cellular adhesion. Studies of disease 
association indicated that NKX2-3 is associated with 
IBD (both Crohn's disease and ulcerative colitis), 
intestinal fibrosis, colon rectal cancer, and dental 
caries. 
Keywords 
NKX2-3, inflammatory bowel disease (IBD), 
Crohn's disease (CD), ulcerative disease (UC), 
homeodomain-containing transcription factor 
Identity 
Other names: CSX3, NK2.3, NKX2.3, NKX2C, 
NKX4-3 
HGNC (Hugo): NKX2-3 
Location: 10q24.2 
DNA/RNA 
Note 
The human NKX2-3 gene has two transcripts. 
NKX2-3-001, ENST00000344586, 2097 nt mRNA 
encoding a protein of 364 amino acids; NKX2-3-
201, ENST00000622383, 1986 nt mRNA encoding 
a protein of 296 amino acids. 
Description 
The gene has two exons and one intron. 
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Chromosomal location of human NKX2-3 gene. NKX2-3 gene is located on chr 10q24.2, size 3592 bp, starting at 101292690 
bp and ending at 101296281 bp from the pter (the end of short arm) of the chromosome 10. The gene orientation is on the plus 
strand. The NKX2-3 gene consists of 2 exons 527 bp (101292690-101293248 nt) and 1540 bp (101294742-101298281 nt) 
respectively, an intron 1496 bp (101293248-101294742 nt). GOT1: glutamic-oxaloacetric transaminase 1 soluble; SLC25A28: 
solute carrier family 25 (mitochondrial iron transporter) member 28; ENTP7: ectonucleoside triphosphate diphophohydrolase 7. 
 
 
Transcription 
The transcription takes place in a centromere --> 
telomere orientation. The length of the processed 
mRNA is about 2094 nucleotides. 
Pseudogene 
Not known. 
Protein 
Note 
The NKX2-3 protein is a 364-amino acid (molecular 
weight 38405.63g/mol) protein. 
Description 
The NKX2-3 protein (364 amino acids) translated 
from the long transcript contains a TN domain 
(residues 10-19), HD domain (residues 148-207), SD 
domain (residues 222-238) and TAD domain 
(residues 239-364). 
Expression 
Expression is mainly observed in pharynx, small 
intestine, liver, spleen, heart, lymph node, thyroid, 
adrenal gland, breast, skin, ovary, prostate, testis, 
and retina. 
Localisation 
Nucleus, but also observed outside the nucleus. 
Function 
NKX2-3 is a nuclear transcription factor that plays 
an important role in the regulation of gene 
transcription. Studies from siRNA knockdown 
followed by cDNA profiling indicate that many 
genes are regulated by NKX2-3.  
This indicates involvement of NKX2-3 in the 
regulation of transcription, of immune and 
inflammatory response, cell growth and 
proliferation, cell adhesion, metabolic processes, 
angiogenesis, lymph-angiogenesis, and others (Yu et 
al., 2011). 
Results from NKX2-3 deficient mice and other 
studies demonstrate that NKX2-3 is essential for 
intestine and spleen development (Pabst et al., 1999; 
Pabst et al., 2000).  
NKX2-3 is required for heart formation (Fu et al., 
1998) and salivary gland and tooth morphogenesis 
and plays a role during pharyngeal organogenesis 
(Biben et al., 2002).  
NKX2-3 is essential for B cell maturation and T cell 
dependent immune response (Shaffer et al., 2013), 
and regulates leukocyte homing through local 
control of cellular adhesion molecules including 
MADCAM-1 and VCAM in mice (Wang et al., 
2000) and IBD patients (our unpublished data). 
 
 
Human NKX2-3 mRNA. The gene for NKX2-3 consists of two exons of 527 and 1540 bp, respectively. The intron is 1496 bp. 
Positions of start (cDNA 179 nt) and stop (cDNA 1534 nt) codons are indicated. These data refer to ENSEMBL transcript. 
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Human NKX2-3 protein. The NKX2-3 protein is a 364-amino acid (molecular weight 38405.63g/mol) protein including a TN 
domain (tinman domain; transcription repressor domain), HD domain (homeodomain, 60 aa), SD domain (NK2 specific domain), 
and TAD domain (transcriptional activation domain). 
 
 
Nkx2-3 and regulation of the arteriovenous 
endothelial profile 
Individual transcription factors interact in a complex 
network to regulate the arteriovenous profile. 
Aranguren et al. 2013 examined the expression of 64 
known arterial and 12 known venous genes from 
freshly isolated arterial and venous endothelial cells 
from human umbilical cord. The expression of 
approximately 36% of the examined arterial genes 
was found to be regulated by NKX2-3 (Aranguren et 
al., 2013). 
Nkx2-3 and lymphoid tissue development 
It remains to be determined whether the formation of 
enteric lymphatic capillaries is affected by the 
absence of Nkx2-3, similar to the observed reduction 
of Peyer's patches. In contrast to the leukocyte 
homing in pLNs and Peyer's patches, the spleen 
lacks high endothelial venules (HEVs) and requires 
no L-selectin binding for subsequent leukocyte 
extravasation. Evidence indicated that the integrity 
of the marginal sinus and the proper vascular 
segregation of the red pulp was controlled by NKX2-
3 (Balogh et al., 2007). 
Czömpöly et al. 2011 found that the disruption of 
Nkx2-3 expression in mice, the spleen develops a 
peripheral lymph node (pLN)-like mRNA 
expression signature, coupled with the appearance of 
HEVs. These HEV-like vessels undergo postnatal 
maturation and progressively replace MAdCAM-1 
by pLN addressin together with the display of 
CCL21 arrest chemokine, reminiscent of HEV 
formation in pLNs (Czömpöly et al., 2011). This 
transformation of splenic vasculature into pLN-like 
vessels emphasizes the importance of Nkx2-3 in 
correct vessel formation for spleen ontogeny in 
mammals. 
Kellermayer et al. 2011 reported that Nkx2.3-
deficient mice develop splenic and gut-associated 
vascular and lymphoid tissue abnormalities with 
disordered segregation of T- and B- cells. Splenic 
defects include absence of the marginal sinus 
vasculature and an atrophic red pulp sinus network 
with an extensive network of lymphocyte-filled 
endothelial sacs lined by cells expressing LYVE-1, a 
marker associated with lymphatic endothelium cells 
(Kellermayer et al., 2011).  
This raises the possibility that endothelial 
differentiation and maturation may be affected by 
altered expression of Nkx2-3. 
Homology 
NKX2-3 is a homeodomain protein belonging to the 
NK2 family.  
The other NK2 family members are Nkx2-1 (at 
14q13), Nkx2-2 (at 20p11), Nkx2-3 (at 10q24.2), 
Nkx2-4 (at 20p11), Nkx2-5, Nkx2-6, Nkx2-8, Nkx2-
9 (at 14q13), and Nkx2-10. 
Orthologs of NKX2-3 show a high similarity with 
the homologues in other species, such as 88.46% (nt) 
and 90.86% (aa) with mouse, 60% (aa) with chicken, 
79% (nt) with Xenopus laevis, 76.29% (nt) with 
zebrafish, 20% (aa) with fruit fly, and 33% (aa) with 
worm. 
Mutations 
A total of 304 genetic variants are documented, 
including 128 upstream and 87 downstream of the 
gene, 5 variants in the 5' prime and 15 in the 3' primer 
untranslated regions, 26 missense and 17 
synonymous variants in exons, 23 variants in introns, 
and 2 in-frame deletions. 
NKX2-3 (NK2 homeobox 3)  
 
 
 
 
 
Atlas Genet Cytogenet Oncol Haematol. 2016; 20(1) 21 
 
 
Mutations in human NKX2-3 gene. A. The base number at the beginning and the end of each exon is shown. Genetic 
variations rs10883365 and rs11190140 in 5'-prime upstream are the most used for genetic association study, and rs888208 in 
3'UTR is used for allele specific expression. TMP_ESP_10_101294794-101294796 GAA/- in Exon 2 is an in-frame deletion. Of 
the 26 missense genetic variants only three, rs201429667 (p.A49T), rs79873574 (p.P145T, and rs15105391 (p.L358W) have 
been observed in multiple studies. Of the 17 synonymous variants five have been observed in multiple studies with high MAF 
(minor allele frequency): rs41290504 (MAF: 0.483), rs145887258 (MAF: 0.001), rs184601313 (MAF: 0.001), rs113459553 (MAF: 
0.039), and rs78122843 (MAF: 0.006) in amino acid residue 49, 80, 156, 185, and 194 respectively. B.The base number at the 
beginning and the end of each exon is shown. The somatic mutations are shown from left to right: COSM71840 p.T10I, 
COSM1345223 p.D35G, COSM913762 p.A43V, COSM426905 p.A49A, COSM124757 p.G52E, COSM1217392 p.L70S, 
COSM3686464 p.S102R, COSM2057374 p.S102S, COSM1638416 p.E109Q, COSM465162 p.R165H, COSM1345224 pA216T, 
COSM404952 C817_837del21 in-frame, and COSM1217393 p.R362L. 
 
Somatic 
A total of 13 somatic mutations have been reported: 
one is a 21 bp deletion, two are synonymous variants, 
and 10 missense variants. 
Histological examination showed all the mutations 
are observed in carcinoma. 
Implicated in 
Colorectal cancer (CRC) 
Loss of heterozygosity on chromosome 10 where 
IL10 is located was observed in sporadic CRC. RT-
PCR results indicated that the NKX2-3 gene is down 
regulated (Wang et al., 2008).  
A high expression of NKX2-3 was found in the CRC 
experimental group compared to the control group 
(Li et al., 2012). 
CRC with synchronous liver 
metastasis 
NKX2-3 with other 6 genes was incorporated into a 
genetic model for estimating chemotherapy 
sensitivity.  
The result from 30 ACC (advanced colorectal 
cancer) patients (13 were assigned to experimental 
group and 17 to the control group) showed an overall 
accurate prediction rate of 99.3% (Lu et al., 2013). 
Liver metastases 
NKX2-3 is expressed to a low level in liver 
metastases than in primary tumors and normal 
enterochromaffin cells (Leja et al., 2009). 
Inflammatory bowel disease (IBD) 
NKX2-3 was first identified as IBD susceptibility 
gene from a GWAS study in 2006 (Wellcome Trust 
Case Control, 2007) and then it was replicated in 
several cohorts in both CD and US (Parkes et al., 
2007; Franke et al., 2008; Barrett et al., 2008). The 
association is widely studied with genetic variations 
rs10883365 and rs11190140, in different IBD 
populations, including Japanese population (484 CD 
and 470 controls (Yamazaki et al., 2009), Dutch-
Belgian (2731IBD: 1656 CD and 1075UC) 
(Weersma et al., 2009), Eastern European IBD 
patients (810 CD and 428 UC) (Meggyesi et al., 
2010), Central Pennsylvania population in US (Yu et 
al., 2009), Italian cohort (both CD and UC, adult and 
pediatric IBD) (Latiano et al., 2011), and Lithuanian-
Latvian population (444 UC and 1154 controls) 
(Skieceviciene et al., 2013). A specific association of 
NKX2-3 rs1088365 with smoking CD patients has 
been observed (310 CD and 976 controls) (van der 
Heide et al., 2010). These studies have been 
reviewed (Cho and Brant, 2011; Van Limbergen et 
al., 2014). 
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Studies on genetic association of Nkx2-3 gene with IBD. 
 
A recent comprehensive meta-analysis of 17 studies 
involving 17329 patients and 18029 controls showed 
a significantly increased CD or UC risk in persons 
carrying a G allele at rs10883365 polymorphism 
(A/G) compared with those with an A allele. (OR = 
1.226, 95%CI: 1.177-1.277 and OR = 1.274, 95%CI: 
1.175-1.382 respectively).  
In the subgroup analysis, a significantly increased 
CD risk was found in both Europeans and Asians. 
For rs11190140 polymorphism (C/T) and CD risk, 
the risk estimate for the allele contrast was OR = 
1.201 (1.136-1.269) (Lu et al., 2014). 
Prognosis 
Results from a study in 572 CD, 328 UC patients, 
437 non-IBD, and 137 healthy controls using 29 
biomarkers, 4 genetic markers including NKX2-3, 8 
serological markers, and 17 inflammatory markers, 
indicated that these markers can differentiate non-
IBD from CD and UC patients (Plevy et al., 2013). 
Intestinal fibrosis 
Intestinal fibrosis is among the most common 
complications of IBD, and is usually defined as an 
excessive accumulation of scar tissue in the 
intestinal wall. Severe fibrosis is seen in up to 30% 
of patients with CD, a high proportion of them 
require surgery.  
In addition, endothelial-to-mesenchymal transition 
(EndoMT) results in the trans-differentiation of 
intestinal mucosal microvascular cells (HIMEC) into 
mesenchymal cells.  
This indicates that the intestinal microvasculature 
may also contribute to IBD-associated fibrosis 
(Rieder et al., 2011). 
Nkx2-3 is highly expressed in the gut mesenchyme, 
such as myofibroblasts and the smooth muscle cells 
of the muscularis mucosae. Myofibroblasts are 
known to play key roles in wound healing and 
fibrosis. Known Nkx2-3 regulation of genes 
mediating fibrogenesis and wound healing, such as 
endothelins, angiotensin converting enzyme, and 
angiotensin-II, and nitric oxide, may result in active 
deposition of ECM resulting in the characteristic 
fibrosis of CD (Yu et al., 2011). 
Interestingly, related Nkx2.5 is a known repressor of 
myofibroblast α-smooth muscle actin (α-SMA) gene 
transcription in the lung (Hu et al., 2010). Similarly, 
aberrant Nkx2-3 expression in the gut may result in 
increased intestinal myofibroblast differentiation 
intestinal fibrosis. We note that the Nkx2-3-
regulated transcription factor KLF-4 (gut-enriched 
Krüppel-like factor) represses α-SMA gene 
expression by interacting with Smad3 (TGF-β 
signaling) to prevent Smad3 binding, resulting in 
reduced myofibroblast differentiation (Hu et al., 
2007). 
Dental caries 
Dental caries, also known as tooth decay or a cavity, 
is an infection, bacterial in origin. It causes 
demineralization and destruction of the hard tissues 
of the teeth (enamel, dentin and cementum) as a 
result of the production of acid by bacterial 
fermentation of food debris accumulated on the tooth 
surface. In a GWAS study with 518987 genetic 
variations NKX2-3 was shown to be a suggestive 
genetic association with dental caries pattern in the 
permanent dentition (Shaffer et al., 2013). 
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Schematic representation of 10q24 and 12p13 regions implicated in the t(10;12). Genomic representation of t(10;12) ETV6 
(exon 3)-GOT1 (exon 12) fusion is in frame. The fusion transcript was identified by RT-PCR with primers located in the exon 6 of 
ETV6 and the exon 3 of GOT1 followed by sequence analysis. The sterile alpha motif (SAM) domain (exons 2 to 4) responsible 
for hetero- and homodimerization with other ETV6 protein and possibly other ETS family members, are indicated. 
 
Breakpoints 
A ETV6-GOT1 fusion contains a chimeric transcript 
containing ETV6 sequence fused to genomic 
sequences located at 22961 bp 3' to GOT1 and 79407 
bp 5' to NK2 transcription factor related, locus 3 
(NKX2-3). This may result in the dysregulation of 
NKX2-3, which lies adjacent to the breakpoint 
(Struski et al., 2008). 
To be noted 
miRNAs targeting human Nkx2-3 
The top miRNAs binding the 3'-UTR of the human 
NKX2-3 transcript were identified using TargetScan 
v6.2 (Lewis et al., 2005) and Miranda algorithm v4.0 
(Betel et al., 2006) with parameters of >8-mer 
matches with mirSVR scores <= -1 and PhastCons 
score >= 0.6 BP. Identified miRNAs included 
members of the miR-92a microRNA precursor 
family of highly conserved miRNAs (miR-25, miR-
92a, miR-92b and miR-363). The miR-92a family 
plays an important role in regulating mammalian 
organs including heart and lungs, and immune 
system, formation of blood vessels, and development 
of endothelial cells. Inhibition of miR-92a can 
enhance angiogenesis and viability of endothelial 
cells (Zhang et al., 2014). miRNA92a family and 
miRNA-32 affect expression of endothelial Kruppel-
like factors KLF2 and KLF-4, possibly though 
regulation of Nkx2-3 expression (Loyer et al., 2014). 
Epigenetic modification of genetic variant 
Rs11190140 is a C/T variation followed by G. The 
C allele is in a CG dinucleotide. The C is subjected 
to methylation. The genetic variation and epigenetic 
modification affect the NFAT transcription factor 
binding to the DNA, T< nonmethylated C< 
methylated C (John et al., 2011).  
Nkx2-3 allelic expression imbalance in human 
IBD colonic mucosa 
Arai et al. 2011 (Arai et al., 2011) examined the 
expression of Nkx2-3 mRNA from colonic mucosa 
from Japanese patients with IBD. Allelic expression 
ratios of NKX2.3 mRNA transcribed from risk 
haplotype to the non-risk haplotype in the involved 
mucosa from 10 IBD patients were significantly 
higher than the allelic ratio of respective genomic 
DNA (p = 0.00195) (Arai et al., 2011). This observed 
allelic expression imbalance supports the idea that 
the risk haplotype of NKX2.3 confers susceptibility 
to UC through increasing expression of NKX2.3 
mRNA in the colonic mucosa. 
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